Tudor Investment Corp’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $403K | Buy |
+1,796
| New | +$448K | ﹤0.01% | 2967 |
|
|
2025
Q3 | – | Sell |
-15,596
| Closed | -$4.26M | – | 3797 |
|
|
2025
Q2 | $4.02M | Buy |
+15,596
| New | +$3.72M | 0.01% | 1218 |
|
|
2025
Q1 | – | Sell |
-7,724
| Closed | -$1.77M | – | 3574 |
|
|
2024
Q4 | $1.77M | Buy |
7,724
+6,364
| +468% | +$1.53M | 0.01% | 1338 |
|
|
2024
Q3 | $332K | Sell |
1,360
-114,586
| -99% | -$25.6M | ﹤0.01% | 2269 |
|
|
2024
Q2 | $22.2M | Sell |
115,946
-55,132
| -32% | -$11.2M | 0.11% | 148 |
|
|
2024
Q1 | $33.9M | Buy |
171,078
+47,498
| +38% | +$8.7M | 0.22% | 59 |
|
|
2023
Q4 | $21.3M | Buy |
+123,580
| New | +$19M | 0.17% | 111 |
|
|
2023
Q3 | – | Sell |
-17,259
| Closed | -$3.12M | – | 2779 |
|
|
2023
Q2 | $3.77M | Sell |
17,259
-34,140
| -66% | -$7.61M | 0.05% | 570 |
|
|
2023
Q1 | $11.3M | Buy |
51,399
+25,062
| +95% | +$5.44M | 0.17% | 120 |
|
|
2022
Q4 | $5.48M | Buy |
26,337
+22,846
| +654% | +$5.02M | 0.11% | 223 |
|
|
2022
Q3 | $762K | Buy |
+3,491
| New | +$795K | 0.02% | 1113 |
|
|
2021
Q4 | – | Sell |
-1,413
| Closed | -$372K | – | 2911 |
|
|
2021
Q3 | $372K | Buy |
+1,413
| New | +$386K | 0.01% | 1872 |
|
|
2020
Q4 | – | Sell |
-2,498
| Closed | -$428K | – | 1582 |
|
|
2020
Q3 | $428K | Buy |
+2,498
| New | +$461K | 0.02% | 879 |
|
|
2020
Q2 | – | Sell |
-2,819
| Closed | -$415K | – | 1380 |
|
|
2020
Q1 | $415K | Buy |
+2,819
| New | +$449K | 0.04% | 563 |
|
|
2019
Q2 | – | Sell |
-7,959
| Closed | -$827K | – | 1301 |
|
|
2019
Q1 | $827K | Buy |
+7,959
| New | +$822K | 0.03% | 526 |
|
|
2018
Q4 | – | Sell |
-20,617
| Closed | -$2.38M | – | 1204 |
|
|
2018
Q3 | $2.38M | Sell |
20,617
-2,125
| -9% | -$233K | 0.06% | 239 |
|
|
2018
Q2 | $2.36M | Buy |
+22,742
| New | +$2.3M | 0.08% | 214 |
|
|
2018
Q1 | – | Sell |
-4,377
| Closed | -$371K | – | 1200 |
|
|
2017
Q4 | $371K | Buy |
+4,377
| New | +$362K | 0.01% | 723 |
|
|
2017
Q3 | – | Sell |
-7,983
| Closed | -$622K | – | 1227 |
|
|
2017
Q2 | $622K | Sell |
7,983
-16,512
| -67% | -$1.18M | 0.02% | 492 |
|
|
2017
Q1 | $1.76M | Buy |
+24,495
| New | +$1.69M | 0.05% | 213 |
|
|
2016
Q4 | – | Sell |
-17,487
| Closed | -$1.13M | – | 1574 |
|
|
2016
Q3 | $1.13M | Buy |
17,487
+9,242
| +112% | +$615K | 0.03% | 357 |
|
|
2016
Q2 | $521K | Sell |
8,245
-9,586
| -54% | -$565K | 0.01% | 808 |
|
|
2016
Q1 | $1.03M | Buy |
17,831
+8,731
| +96% | +$494K | 0.03% | 503 |
|
|
2015
Q4 | $489K | Buy |
+9,100
| New | +$513K | 0.01% | 900 |
|
|
2015
Q3 | – | Sell |
-6,500
| Closed | -$366K | – | 1716 |
|
|
2015
Q2 | $366K | Buy |
+6,500
| New | +$410K | 0.01% | 985 |
|
|
2015
Q1 | – | Sell |
-5,100
| Closed | -$286K | – | 1586 |
|
|
2014
Q4 | $286K | Buy |
+5,100
| New | +$266K | 0.01% | 1065 |
|
|
2014
Q2 | – | Sell |
-10,683
| Closed | -$477K | – | 1293 |
|
|
2014
Q1 | $477K | Sell |
10,683
-6,336
| -37% | -$285K | 0.02% | 553 |
|
|
2013
Q4 | $801K | Buy |
+17,019
| New | +$861K | 0.04% | 294 |
|
|
2013
Q3 | – | Sell |
-8,000
| Closed | -$361K | – | 936 |
|
|
2013
Q2 | $361K | Buy |
+8,000
| New | +$380K | 0.03% | 465 |
|
Other funds holding RMD
VCM
VPM
DAM
Tudor Investment Corp's RMD Position: Q1 2026 in Review
Tudor Investment Corp opened a new position in ResMed (RMD) in Q1 2026: 1,796 shares worth $403K. The stake represents ﹤0.01% of the portfolio and ranks #2967 among its holdings. This is a return to the name: Tudor Investment Corp previously reported a position in RMD as recently as Q2 2025.
Tudor Investment Corp first reported a position in RMD in Q2 2013 and has held it in 29 quarters since. The position peaked at $33.9M in Q1 2024. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.
- Tudor Investment Corp held 1,796 shares of ResMed worth $403K as of Q1 2026.
- ResMed was a new Tudor Investment Corp position in Q1 2026.
- ResMed made up ﹤0.01% of Tudor Investment Corp's portfolio in Q1 2026, its #2967 holding.
- Tudor Investment Corp first reported a position in ResMed in Q2 2013 and has held it in 29 quarters since.
- Tudor Investment Corp's ResMed position peaked at $33.9M in Q1 2024.
- 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.
Based on Tudor Investment Corp's 13F filing for Q1 2026, filed 15 May 2026.